Literature DB >> 28252266

Adjuvant Sunitinib in Renal-Cell Carcinoma.

Sheng Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28252266     DOI： 10.1056/NEJMc1616636

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

Authors:  Melissa García-Caballero; Jenny Paupert; Silvia Blacher; Maureen Van de Velde; Ana Rodríguez Quesada; Miguel Angel Medina; Agnès Noël
Journal:  J Hematol Oncol       Date:  2017-06-19       Impact factor: 17.388

2.  Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study.

Authors:  Zhimin Su; Linbin Lu; Fuyu Chen; Jianhui Chen; Xiong Chen
Journal:  Cancer Manag Res       Date:  2021-11-20       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.